Current Imaging Trends of PET, SPECT, and Advanced MRI in Gliomas and Neurodegenerative Disorders

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".

Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 6758

Special Issue Editor


E-Mail
Guest Editor
Nuclear Medicine Department, University Hospital of Ioannina, Stavros Niarchos Avenue, 45500 Ioannina, Greece
Interests: brain tumors and neurodegenerative disorders; glioma imaging with SPECT, PET and MRI; neurodegenerative disorder imaging with SPECT and PET

Special Issue Information

Dear Colleagues,

Over the years, neuroimaging has evolved into an indispensable tool in the clinical workup of patients with diseases of the central nervous system. Morphological patterns alongside functional and metabolic pathways can be visualized with magnetic resonance imaging (MRI), positron emission tomography (PET), and single-photon emission computed tomography (SPECT); the development of various MRI techniques and the formulation of novel PET and SPECT radioligands are shedding light on the in vivo comprehension of these disorders.

Gliomas and neurodegenerative diseases require the input of multiple imaging disciplines for their diagnosis and understanding. Because their nature extends beyond gross structural patterns, down to the cellular and molecular level, neuroimaging biomarkers aim to provide critical non-invasive insight into their underlying biology. This is useful for patients in a clinical setting but can also be used for the targeted recruitment to clinical trials. This Special Issue of Diagnostics overviews the principles, strong points and limitations, current clinical applications, and future perspectives of advanced MRI, PET, and SPECT in the diagnosis and management of neurodegenerative diseases and gliomas.

Dr. Spyridon Tsiouris
Guest Editor

Keywords

  • Glioma
  • Neurodegenerative diseases
  • Metabolic brain imaging
  • PET
  • Amino acid PET
  • MRI
  • Perfusion-weighted MRI
  • Diffusion-weighted MRI
  • MR spectroscopy
  • Hybrid PET/CT
  • Hybrid PET/MRI
  • Blood–brain barrier

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 2414 KiB  
Article
Regional Cerebral Blood Flow Correlates of Neuropsychiatric Symptom Domains in Early Alzheimer’s Disease
by Hyeonseok Jeong, Ilhyang Kang, Jong-Sik Park, Seung-Hee Na, Seunghee Kim, Sujung Yoon, In-Uk Song and Yong-An Chung
Diagnostics 2022, 12(5), 1246; https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics12051246 - 17 May 2022
Cited by 4 | Viewed by 1671
Abstract
Although various neuropsychiatric symptoms are frequently accompanied with Alzheimer’s disease (AD) and pose a substantial burden to both patients and caregivers, their neurobiological underpinnings remain unclear. This study investigated associations between regional cerebral blood flow (rCBF) and neuropsychiatric symptom domains in early AD. [...] Read more.
Although various neuropsychiatric symptoms are frequently accompanied with Alzheimer’s disease (AD) and pose a substantial burden to both patients and caregivers, their neurobiological underpinnings remain unclear. This study investigated associations between regional cerebral blood flow (rCBF) and neuropsychiatric symptom domains in early AD. A total of 59 patients with early AD underwent brain technetium-99m hexamethylpropylene amine oxime (99mTc-HMPAO) single-photon emission computed tomography (SPECT) scans. Neuropsychiatric symptoms were assessed by the Neuropsychiatric Inventory and clustered into the affective, apathy, hyperactivity, and psychotic domains. A voxel-wise multiple regression analysis was performed with four domain scores as independent variables and age, sex, and Mini-Mental State Examination scores as covariates. The affective domain score was negatively correlated with rCBF in the prefrontal cortex, thalamus, and caudate. The apathy domain score showed inverse correlations with rCBF in the prefrontal and pre/postcentral gyri and midbrain. Patients with higher hyperactivity domain scores had increased rCBF in the prefrontal and temporal lobes. The psychotic symptom domain was positively correlated with rCBF in the cuneus and negatively associated with rCBF in the prefrontal, cingulate, and occipital regions and putamen. The score of each neuropsychiatric symptom domain showed the differential correlates of brain perfusion, while altered rCBF in the prefrontal cortex was found in all domains. Although preliminary, our results may suggest common and distinct patterns of rCBF underlying neuropsychiatric symptoms in early AD. Further studies with larger samples and control participants are warranted to confirm these findings. Full article
Show Figures

Figure 1

13 pages, 2168 KiB  
Article
Anosognosia in Dementia: Evaluation of Perfusion Correlates Using 99mTc-HMPAO SPECT and Automated Brodmann Areas Analysis
by Varvara Valotassiou, Nikolaos Sifakis, Chara Tzavara, Evi Lykou, Niki Tsinia, Vasiliki Kamtsadeli, Dimitra Sali, George Angelidis, Dimitrios Psimadas, Eudoxia Theodorou, Ioannis Tsougos, Sokratis G. Papageorgiou, Panagiotis Georgoulias and John Papatriantafyllou
Diagnostics 2022, 12(5), 1136; https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics12051136 - 04 May 2022
Viewed by 2247
Abstract
(1) Background: Considerable inconsistency exists regarding the neural substrates of anosognosia in dementia in previous neuroimaging studies. The purpose of this study was the evaluation of anosognosia perfusion correlates across various types of dementia using automated Brodmann areas (BAs) analysis and comparison with [...] Read more.
(1) Background: Considerable inconsistency exists regarding the neural substrates of anosognosia in dementia in previous neuroimaging studies. The purpose of this study was the evaluation of anosognosia perfusion correlates across various types of dementia using automated Brodmann areas (BAs) analysis and comparison with a database of normal subjects. (2) Methods: We studied 72 patients: 32 with Alzheimer’s disease, 26 with frontotemporal dementia—FTD (12 behavioral FTD, 9 semantic FTD, 5 Progressive Non-Fluent Aphasia), 11 with corticobasal syndrome, and 3 with progressive supranuclear palsy. Addenbrook’s Cognitive Examination—Revised (ACE-R) mean(±SD) was 55.6(±22.8). For anosognosia measurement, the Anosognosia Questionnaire—Dementia was used. Total anosognosia score mean(±SD) was 22.1(±17.9), cognitive anosognosia score mean(±SD) was 18.1(±15.1) and behavioral–mood anosognosia score mean(±SD) was 3.3(±4.7). (3) Results: Higher anosognosia total score was associated with hypoperfusion in the inferior temporal, anterior cingulate, and inferior frontal cortices of the right hemisphere (BAs 20R, 24R, 32R, 45R). Higher anosognosia cognitive score was correlated with hypoperfusion in the left middle and anterior temporal cortices, and right dorsal anterior cingulate cortex (BAs 21L, 22L, 32R). No association was found with behavioral–mood anosognosia. (4) Conclusions: Automated analysis of brain perfusion Single Photon Emission Computed Tomography could be useful for the investigation of anosognosia neural correlates in dementia. Full article
Show Figures

Figure 1

9 pages, 1416 KiB  
Article
Combined Diagnostic Accuracy of Diffusion and Perfusion MR Imaging to Differentiate Radiation-Induced Necrosis from Recurrence in Glioblastoma
by Ankush Jajodia, Varun Goel, Jitin Goyal, Nivedita Patnaik, Jeevitesh Khoda, Sunil Pasricha and Munish Gairola
Diagnostics 2022, 12(3), 718; https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics12030718 - 15 Mar 2022
Cited by 3 | Viewed by 2019
Abstract
We aimed to use quantitative values derived from perfusion and diffusion-weighted MR imaging (PWI and DWI) to differentiate radiation-induced necrosis (RIN) from tumor recurrence in Glioblastoma (GBM) and investigate the best parameters for improved diagnostic accuracy and clinical decision-making. Methods: A retrospective analysis [...] Read more.
We aimed to use quantitative values derived from perfusion and diffusion-weighted MR imaging (PWI and DWI) to differentiate radiation-induced necrosis (RIN) from tumor recurrence in Glioblastoma (GBM) and investigate the best parameters for improved diagnostic accuracy and clinical decision-making. Methods: A retrospective analysis of follow-up MRI with new enhancing observations was performed in histopathologically confirmed subjects of post-treated GBM, who underwent re-surgical exploration. Quantitative estimation of rCBV (relative cerebral blood volume) from PWI and three methods of apparent diffusion coefficient (ADC) estimation were performed, namely ADC R1 (whole cross-sectional area of tumor), ADC R2 (only solid enhancing lesion), and ADC R3 (central necrosis). ROC curve and logistic regression analysis was completed. A confusion matrix table created using Excel provided the best combination parameters to ameliorate false-positive and false-negative results. Results: Forty-four subjects with a mean age of 46 years (range, 19–70 years) underwent re-surgical exploration with RIN in 28 (67%) and recurrent tumor in 16 (33%) on histopathology. rCBV threshold of >3.4 had the best diagnostic accuracy (AUC = 0.93, 81% sensitivity and 89% specificity). A multiple logistic regression model showed significant contributions from rCBV (p < 0.001) and ADC R3 (p = 0.001). After analysis of confusion matrix ADC R3 > 2032 × 10−6 mm2 achieved 100% specificity with gain in sensitivity (94% vs. 56%). Conclusions: A combination of parameters had better diagnostic performance, and a stepwise combination of rCBV and ADC R3 obviated unnecessary biopsies in 10% (3/28), leading to improved clinical decision-making. Full article
Show Figures

Figure 1

Back to TopTop